OBJECTIVES: Different probiotic strains used in clinical trials have shown prophylactic properties in different inflammatory diseases of the gastrointestinal tract. This study was aimed to investigate the influence of Escherichia coli strain Nissle 1917 (EcN) components on the integrity of the Caco-2 cell monolayer (human adenocarcinoma cell line). METHODS: The effect of supernatant of EcN suspension and lipopolysaccharide (LPS) isolated from EcN (in concentrations from 0.001 to 1 000 µg/ml) on paracellular transport of 14C-mannitol marker through epithelial cell monolayer was estimated. RESULTS: Both LPS and EcN supernatant exerted almost the same effect; whereas no effect was shown using high concentrations (100 and 1 000 µg/ml), low concentrations (0.001, 0.1 and 1 µg/ml) significantly decreased permeability of 14C-mannitol. Concentration (0.001 µg/ml) decreased 14C-mannitol permeability approximately about 20% (LPS) and 30% (EcN supernatant). To elucidate the observed changes in monolayer permeability ("tighter monolayer") induced by concentrations of LPS or supernatant, media able to open epithelial intercellular junctions were used. The effects of Ca2+-free transport medium and of medium containing 5, 10, 20, 50, and 100% of Ca2+ on the 14C-mannitol transport in the presence of the lowest (0.001 µg/ml) and high (100 µg/ml) concentrations of LPS were studied. Using Ca2+-free medium both concentrations of LPS significantly decreased apparent permeability coefficient (Papp) of 14C-mannitol indicating that changes of 14C-mannitol permeability are independent of dimensions of paracellular spaces. CONCLUSION: The decrease of 14C-mannitol permeability caused by EcN LPS indicates the ability of components of probiotic EcN strain to restore disrupted epithelial barrier.

Institute of Experimental Biopharmaceutics Joint Research Center of the Academy of Sciences of the Czech Republic and PRO MED CS Praha a s

Institute of Experimental Biopharmaceutics Joint Research Centre of PRO MED CS Praha a s and the Academy of Sciences of the Czech Republic Heyrovského 1207 Hradec Králové Czech Republic

Institute of Experimental Biopharmaceutics Joint Research Centre of PRO MED CS Praha a s and the Czech Academy of Sciences Czech Republic

Institute of Experimental Biopharmaceutics Joint Research Centre of the Czech Academy of Sciences and PRO MED CS Praha a s Hradec Králové Czech Republic

Institute of Experimental Medicine v v i Academy of Sciences of the Czech Republic

Institute of Microbiology v v i Academy of Sciences of the Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc12027174

003      

CZ-PrNML

005      

20160407182036.0

007      

ta

008      

120816s2010 sw f 000 0#eng||

009      

AR

035    __

$a (PubMed)21187838

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sw

100    1_

$a Štětinová, Věra $u Institute of Experimental Biopharmaceutics, Joint Research Centre of PRO.MED.CS Praha a.s. and the Czech Academy of Sciences, Czech Republic. Stetinova@uebf.cas.cz $7 xx0117623

245    10

$a Caco-2 cell monolayer integrity and effect of probiotic Escherichia coli Nissle 1917 components / $c V. Stetinova, L. Smetanova, J. Kvetina, Z. Svoboda, Z. Zidek, H. Tlaskalova-Hogenova

520    9_

$a OBJECTIVES: Different probiotic strains used in clinical trials have shown prophylactic properties in different inflammatory diseases of the gastrointestinal tract. This study was aimed to investigate the influence of Escherichia coli strain Nissle 1917 (EcN) components on the integrity of the Caco-2 cell monolayer (human adenocarcinoma cell line). METHODS: The effect of supernatant of EcN suspension and lipopolysaccharide (LPS) isolated from EcN (in concentrations from 0.001 to 1 000 µg/ml) on paracellular transport of 14C-mannitol marker through epithelial cell monolayer was estimated. RESULTS: Both LPS and EcN supernatant exerted almost the same effect; whereas no effect was shown using high concentrations (100 and 1 000 µg/ml), low concentrations (0.001, 0.1 and 1 µg/ml) significantly decreased permeability of 14C-mannitol. Concentration (0.001 µg/ml) decreased 14C-mannitol permeability approximately about 20% (LPS) and 30% (EcN supernatant). To elucidate the observed changes in monolayer permeability ("tighter monolayer") induced by concentrations of LPS or supernatant, media able to open epithelial intercellular junctions were used. The effects of Ca2+-free transport medium and of medium containing 5, 10, 20, 50, and 100% of Ca2+ on the 14C-mannitol transport in the presence of the lowest (0.001 µg/ml) and high (100 µg/ml) concentrations of LPS were studied. Using Ca2+-free medium both concentrations of LPS significantly decreased apparent permeability coefficient (Papp) of 14C-mannitol indicating that changes of 14C-mannitol permeability are independent of dimensions of paracellular spaces. CONCLUSION: The decrease of 14C-mannitol permeability caused by EcN LPS indicates the ability of components of probiotic EcN strain to restore disrupted epithelial barrier.

650    _2

$a adenokarcinom $x metabolismus $x patologie $7 D000230

650    _2

$a Caco-2 buňky $7 D018938

650    _2

$a radioizotopy uhlíku $7 D002250

650    _2

$a permeabilita buněčné membrány $x účinky léků $7 D002463

650    _2

$a viabilita buněk $x účinky léků $7 D002470

650    _2

$a nádory tračníku $x metabolismus $x patologie $7 D003110

650    _2

$a vztah mezi dávkou a účinkem léčiva $7 D004305

650    _2

$a Escherichia coli $7 D004926

650    _2

$a lidé $7 D006801

650    _2

$a lipopolysacharidy $x farmakologie $7 D008070

650    _2

$a mannitol $x metabolismus $7 D008353

650    _2

$a probiotika $x farmakologie $7 D019936

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Smetanová, Libuše $7 xx0139464 $u Institute of Experimental Biopharmaceutics, Joint Research Centre of PRO.MED.CS Praha a.s. and the Academy of Sciences of the Czech Republic, Heyrovského 1207, Hradec Králové, Czech Republic

700    1_

$a Květina, Jaroslav, $d 1930- $7 jk01071205 $u Institute of Experimental Biopharmaceutics, Joint Research Center of the Academy of Sciences of the Czech Republic and PRO.MED.CS Praha a.s.

700    1_

$a Svoboda, Zbyněk $7 xx0081965 $u Institute of Experimental Biopharmaceutics, Joint Research Centre of the Czech Academy of Sciences and PRO.MED.CS Praha a.s., Hradec Králové, Czech Republic

700    1_

$a Zídek, Zdeněk $7 jk01152582 $u Institute of Experimental Medicine, v.v.i., Academy of Sciences of the Czech Republic

700    1_

$a Tlaskalová, Helena, $d 1938- $7 jn20000402365 $u Institute of Microbiology, v.v.i., Academy of Sciences of the Czech Republic

773    0_

$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 31 Suppl 2(2010), s. 51-56

856    41

$u https://pubmed.ncbi.nlm.nih.gov/21187838 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y m $z 0

990    __

$a 20120816 $b ABA008

991    __

$a 20160407181758 $b ABA008

999    __

$a ok $b bmc $g 949216 $s 784520

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2010 $b 31 Suppl 2 $d 51-56 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352

LZP    __

$b NLK112 $a Pubmed-20120816/11/02